The company
Alaunos Therapeutics, Inc.
TCRT · Nasdaq
TCRT stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 29 weeks. It is 21.6% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 29
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 30 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.unchanged · filed 7 Aug 2026 | 21,353$48K | 00.0% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 19,356$44K | -3,204−14.2% |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 15,497$35K | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026 | 14,063$32K | 00.0% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 11,870$27K | +1,351+12.8% |
| OSAIC HOLDINGS, INC.reduced · filed 14 Aug 2026 | 1,731$3,907 | -48−2.7% |
| Tower Research Capital LLC (TRC)added · filed 11 Aug 2026 | 1,621$3,663 | +38+2.4% |
| Arax Advisory Partnersnew · filed 10 Aug 2026 | 1,216$2,749 | +1,216 |
| UBS Group AGreduced · filed 13 Aug 2026 | 992$2,242 | -1,282−56.4% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 836$1,889 | +183+28.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.